文献速递肝病炎症性肠病

肠道菌群失调通过NLRP3加重原发性硬化性胆管炎小鼠模型的肝病进展

Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis.
PubMed 文献 · Gut · 2019-03-14

本研究在模拟人类原发性硬化性胆管炎的Mdr2敲除小鼠模型中,探究肠-肝轴的作用。Mdr2-/-小鼠出现不利的肠道菌群特征和NLRP3炎症小体活化,肠道菌群失调导致肠屏障功能障碍和细菌易位,转移Mdr2-/-菌群至健康小鼠可诱导肝损伤,而pan-caspase抑制剂IDN-7314可减轻炎症小体活化并改善肝损伤。

要点

  • Mdr2-/-小鼠呈现不利肠道菌群特征并伴NLRP3炎症小体活化
  • Mdr2-/-菌群转移至健康野生型小鼠可诱导显著肝损伤
  • IDN-7314抑制炎症小体活化并改善肝损伤及胆汁酸谱

核心结论

  • MDR2相关胆汁淤积触发肠道菌群失调,内毒素易位至门静脉并激活NLRP3炎症小体,从而加重肝损伤,该过程不主要依赖肝细胞caspase-8,但可被IDN-7314阻断。

研究设计与样本

  • 雄性Mdr2-/-小鼠、Mdr2-/-与肝细胞特异性caspase-8缺失杂交小鼠(Mdr2-/-/Casp8∆hepa)及野生型对照小鼠分别饲养8周或52周,以表征Mdr2缺失对肝脏和肠道(包括胆汁酸和菌群谱)的影响。
  • 使用pan-caspase抑制剂IDN-7314阻断caspase活化。
  • 通过菌群转移实验研究Mdr2-/-相关肠道菌群失调的功能作用。

主要发现

  • Mdr2-/-小鼠显示不利的肠道菌群特征和肠-肝轴中显著的NLRP3炎症小体活化。
  • Mdr2-/-小鼠肠道菌群失调导致肠屏障功能障碍和细菌易位增加,放大肝脏NLRP3介导的先天免疫反应。
  • 将Mdr2-/-菌群转移至健康野生型对照小鼠,在受体小鼠中诱导显著肝损伤,突出肠道菌群失调对疾病进展的因果作用。
  • IDN-7314抑制炎症小体活化、改善肝损伤、逆转血清胆汁酸谱和胆汁淤积相关菌群特征。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: There is a striking association between human cholestatic liver disease (CLD) and inflammatory bowel disease. However, the functional implications for intestinal microbiota and inflammasome-mediated innate immune response in CLD remain elusive. Here we investigated the functional role of gut-liver crosstalk for CLD in the murine Mdr2 knockout (Mdr2-/-) model resembling human primary sclerosing cholangitis (PSC). DESIGN: Male Mdr2-/-, Mdr2-/- crossed with hepatocyte-specific deletion of caspase-8 (Mdr2-/- /Casp8∆hepa) and wild-type (WT) control mice were housed for 8 or 52 weeks, respectively, to characterise the impact of Mdr2 deletion on liver and gut including bile acid and microbiota profiling. To block caspase activation, a pan-caspase inhibitor (IDN-7314) was administered. Finally, the functional role of Mdr2-/- -associated intestinal dysbiosis was studied by microbiota transfer experiments. RESULTS: Mdr2-/- mice displayed an unfavourable intestinal microbiota signature and pronounced NLRP3 inflammasome activation within the gut-liver axis. Intestinal dysbiosis in Mdr2-/- mice prompted intestinal barrier dysfunction and increased bacterial translocation amplifying the hepatic NLRP3-mediated innate immune response. Transfer of Mdr2-/- microbiota into healthy WT control mice induced significant liver injury in recipient mice, highlighting the causal role of intestinal dysbiosis for disease progression. Strikingly, IDN-7314 dampened inflammasome activation, ameliorated liver injury, reversed serum bile acid profile and cholestasis-associated microbiota signature. CONCLUSIONS: MDR2-associated cholestasis triggers intestinal dysbiosis. In turn, translocation of endotoxin into the portal vein and subsequent NLRP3 inflammasome activation contribute to higher liver injury. This process does not essentially depend on caspase-8 in hepatocytes, but can be blocked by IDN-7314.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Liao L, Schneider KM, Galvez EJC, et al. Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis. Gut. 2019. PMID: 30872395. doi:10.1136/gutjnl-2018-316670

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。